Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Successful treatment with corticosteroid in a patient with progressive diaphyseal dysplasia.

× No keyword cloud information.

8 in total

1. [Observations on the Camurati-Engelmann syndrome. Demonstration of changes of the petrous bone using high-resolution computed tomography].

Authors: B Dannenmaier; B Weber
Journal: Rofo Date: 1989-08

2. Diaphyseal dysplasia (Engelmann) treated with corticosteroids.

Authors: J A Lindstrom
Journal: Birth Defects Orig Artic Ser Date: 1974

3. [Engelmann's disease: results of treatment with prednisone].

Authors: P Royer; G Vermeil; P Apostolides; F Engelmann
Journal: Arch Fr Pediatr Date: 1967 Jun-Jul

4. [Camurati-Engelmann disease (progressive diaphyseal dysplasia). Differential diagnostic problems].

Authors: N Mastragelopulos; R Bähr; U Pfister
Journal: Unfallchirurgie Date: 1989-04

5. Corticosteroids in the treatment of Engelmann's disease: progressive diaphyseal dysplasia.

Authors: D T Allen; A M Saunders; W H Northway; G F Williams; I A Schafer
Journal: Pediatrics Date: 1970-10 Impact factor: 7.124

6. Engelmann's disease and the effect of corticosteroids. A case report.

Authors: A M Minford; G J Hardy; W I Forsythe; J M Fitton; V L Rowe
Journal: J Bone Joint Surg Br Date: 1981

7. Progressive diaphyseal dysplasia: genetics and clinical and radiologic manifestations.

Authors: Y Naveh; J K Kaftori; U Alon; J Ben-David; M Berant
Journal: Pediatrics Date: 1984-09 Impact factor: 7.124

8. Progressive diaphyseal dysplasia: evaluation of corticosteroid therapy.

Authors: Y Naveh; U Alon; J K Kaftori; M Berant
Journal: Pediatrics Date: 1985-02 Impact factor: 7.124

8 in total

4 in total

1. Significant Improvement of Clinical Symptoms, Bone Lesions, and Bone Turnover after Long-Term Zoledronic Acid Treatment in Patients with a Severe Form of Camurati-Engelmann Disease.

Authors: Giampiero I Baroncelli; Elena Ferretti; Cecilia M Pini; Benedetta Toschi; Rita Consolini; Silvano Bertelloni
Journal: Mol Syndromol Date: 2017-09-09

Review 2. Camurati-Engelmann disease: review of the clinical, radiological, and molecular data of 24 families and implications for diagnosis and treatment.

Authors: K Janssens; F Vanhoenacker; M Bonduelle; L Verbruggen; L Van Maldergem; S Ralston; N Guañabens; N Migone; S Wientroub; M T Divizia; C Bergmann; C Bennett; S Simsek; S Melançon; T Cundy; W Van Hul
Journal: J Med Genet Date: 2005-05-13 Impact factor: 6.318

3. Camurati-Engelmann disease: unique variant featuring a novel mutation in TGFβ1 encoding transforming growth factor beta 1 and a missense change in TNFSF11 encoding RANK ligand.

Authors: Michael P Whyte; William G Totty; Deborah V Novack; Xiafang Zhang; Deborah Wenkert; Steven Mumm
Journal: J Bone Miner Res Date: 2011-05 Impact factor: 6.741

4. Seropositive Rheumatoid Arthritis with Very Unusual X-ray Findings.

Authors: Laith Alamlih; Mohamed Alkahlout; Abdulrahim Siam; Syed Alam; Abdul-Wahab Al-Allaf
Journal: Eur J Case Rep Intern Med Date: 2018-07-26

4 in total